The mutational landscape of cadherin genes in NSCLC, revealed by our study, also reflects previous findings of frequent CDH2 mutations in invasive cancers (Guvakova et al., 2020; Tuersong et al., 2025). This evidence concerns the gene CDH2 and non-small cell lung carcinoma.